Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-11-04

FDA Approved: EPITOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for EPITOL (carbamazepine) from Teva Pharmaceuticals USA, Inc. The document does not specify the changes (e.g., labeling…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPITOL (carbamazepine)

Snippet

SUPPL AP for EPITOL (CARBAMAZEPINE)